1 / 6

Writing Workshop 7/12/2019

Explore the potential of sigma-1 receptor agonists to enhance mitochondrial function in Alzheimer's disease, focusing on a comparison between wild-type and 3xTg-AD neuron mitochondria. Discover how early changes in mitochondria may contribute to AD pathogenesis.

cili
Download Presentation

Writing Workshop 7/12/2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Writing Workshop 7/12/2019 Isaac Babcock

  2. My writing issues • Clearly explaining complex ideas or methods • My information flow favors the writers knowledge rather then the readers knowledge.

  3. Tips from The Scientist’s Guide To Writing • Read and think about the writer and write and think about the reader. • “You should ask not “what should I write about?” but instead “what does my reader need to hear about?””(chapter 7 page 59) • Make a 2 sentence summary of the story you are trying to tell. Make sure all information aids and doesn’t distract from story summary

  4. If I was the writer what would be the 2 sentence summary, and what information is critical for this story? Sigma-1 receptor agonists have shown to enhance mitochondrial function. If mitochondrial properties from embryonic 3xTg-AD mouse neurons is different from wild type mouse neurons then sigma-1 receptor agonists might ameliorate these deficits and be a potential Alzheimer’s therapeutic. Mitochondrial dysfunction is found in Alzheimer’s disease (AD) patients and animal models. If mitochondrial properties from embryonic 3xTg-AD mouse neurons is different from wild type mouse neurons then early changes in mitochondria may be a key step in AD pathogenesis.

  5. Information necessary to tell this specific story • What is the 3xTg-AD mouse model? • What are the properties of WT neuron mitochondria • What are the properties of 3xTg-AD neuron mitochondria • How does a sigma-1 receptor agonist affect mitochondria in WT and 3xTg-AD neurons This paper does address the information I thought was critical for there story but the flow of information and data was not what I wanted as a reader.

  6. Their flow as the writer versus my ideal flow as the reader Their flow • Mito # and structure in DIV12-14 3xTg-AD and WT neurons • Mito movement in DIV 14 3xTg-AD and WT neurons • Mito # and structure in DIV7-9 3xTgAD and WT neurons • Effect of sigma agonist on mito movement in D7-9 3xTg-AD and WT neurons • Effect of sigma agonist on mito structure and number at DIV7-9 Readers ideal flow • Mito # and structure in DIV7-9 3xTgAD and WT neurons • Mito movement in D7-9 3xTgAD and WT neurons • Mito # and structure in DIV12-14 3xTg-AD and WT neurons • Mito movement in DIV 14 3xTg-AD and WT neurons • Effect of sigma agonist on mito movement in D7-9 3xTg-AD and WT neurons • Effect of sigma agonist on mito structure and number at DIV7-9 • Effect of sigma agonist on mito movement in D14 3xTg-AD and WT neurons • Effect of sigma agonist on mito structure and number at DIV14 • Mito # and structure in DIV7-9 3xTgAD and WT neurons • Effect of sigma agonist on mito structure and number at DIV7-9 • Effect of sigma agonist on mito movement in D7-9 3xTg-AD and WT neurons

More Related